"10.1371_journal.pone.0070909","plos one","2013-08-15T00:00:00Z","Laura Cesaratto; Erika Codarin; Carlo Vascotto; Antonio Leonardi; Mark R Kelley; Claudio Tiribelli; Gianluca Tell","Dipartimento di Scienze Mediche e Biologiche, Università di Udine, Udine, Italy; Fondazione Italiana Fegato, AREA Science Park, Basovizza, Trieste, Italy; Dipartimento di Patologia Cellulare e Molecolare L. Califano Università Federico II di Napoli, Napoli, Italy; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University, Indianapolis, Indiana, United States of America; Dipartimento Scienze Cliniche, Università di Trieste, Trieste, Italy","Conceived and designed the experiments: LC GT. Performed the experiments: LC EC CV AL. Analyzed the data: LC EC CV AL GT. Contributed reagents/materials/analysis tools: MRK. Wrote the paper: LC EC MRK CT GT.","The authors have read the journals policy and declare that they have no conflict of interest, with the exception of Dr. Mark R. Kelley, who is the Chief Scientific Founder and consultant for ApeX Therapeutics, a company that has licensed IP from his work. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","08","Laura Cesaratto","LC",7,TRUE,2,4,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
